485
Views
13
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for Cushing’s disease

, MD &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Denis Ciato, Aizhar G. Mumbach, Marcelo Paez-Pereda & Günter K. Stalla. (2017) Currently used and investigational drugs for Cushing´s disease. Expert Opinion on Investigational Drugs 26:1, pages 75-84.
Read now

Articles from other publishers (12)

Lindsey S. Gaston & Joseph A. Majzoub. 2022. The Pituitary. The Pituitary 51 89 .
Masaaki Yamamoto, Takahiro Nakao, Wataru Ogawa & Hidenori Fukuoka. (2021) Aggressive Cushing’s Disease: Molecular Pathology and Its Therapeutic Approach. Frontiers in Endocrinology 12.
Crossref
Leah T. Braun & Martin Reincke. (2020) What is the role of medical therapy in adrenal-dependent Cushing's syndrome?. Best Practice & Research Clinical Endocrinology & Metabolism 34:3, pages 101376.
Crossref
Giovanna Mantovani, Elena Giardino, Donatella Treppiedi, Rosa Catalano, Federica Mangili, Anna Spada, Maura Arosio & Erika Peverelli. (2019) Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior. Frontiers in Endocrinology 10.
Crossref
Domenico Solari, Rosario Pivonello, Chiara Caggiano, Elia Guadagno, Carmela Chiaramonte, Giovanni Miccoli, Luigi M. Cavallo, Marialaura Del Basso De Caro, Annamaria Colao & Paolo Cappabianca. (2019) Pituitary Adenomas: What Are the Key Features? What Are the Current Treatments? Where Is the Future Taking Us?. World Neurosurgery 127, pages 695-709.
Crossref
G Mantovani, D Treppiedi, E Giardino, R Catalano, F Mangili, P Vercesi, M Arosio, A Spada & E Peverelli. (2019) Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors. Endocrine-Related Cancer 26:2, pages R95-R108.
Crossref
Mariana Fuertes, Julieta Tkatch, Josefina Rosmino, Leandro Nieto, Mirtha Adriana Guitelman & Eduardo Arzt. (2018) New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A. Frontiers in Endocrinology 9.
Crossref
B. S. Yurekli, B. Karaca, A. Kisim, E. Bozkurt, H. Atmaca, S. Cetinkalp, G. Ozgen, C. Yilmaz, S. Uzunoglu, R. Uslu & F. Saygili. (2017) AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells. Journal of Endocrinological Investigation 41:2, pages 233-240.
Crossref
Henrik Oster, Etienne Challet, Volker Ott, Emanuela Arvat, E. Ronald de Kloet, Derk-Jan Dijk, Stafford Lightman, Alexandros Vgontzas & Eve Van Cauter. (2017) The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids. Endocrine Reviews 38:1, pages 3-45.
Crossref
Carmen L. Soto-Rivera & Joseph A. Majzoub. 2017. The Pituitary. The Pituitary 47 83 .
Daniel Cuevas-Ramos, Dawn Shao Ting Lim & Maria Fleseriu. (2016) Update on medical treatment for Cushing’s disease. Clinical Diabetes and Endocrinology 2:1.
Crossref
Xavier Bertagna. (2016) Therapeutic innovations in endocrine diseases – Part 1: New medical treatments for chronic excess of endogenous cortisol (Cushing's syndrome). La Presse Médicale 45:6, pages e201-e204.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.